Abstract:
PURPOSE: A manufacturing method for Momordica charantia granules is provided to be easily carried and taken as a medicine having enhanced antioxidant activities and alpha-glucosidase inhibitory activities. CONSTITUTION: Momordica charantia is cut and dried at 45-55°C for 2-3 days. The dried Momordica charantia is pulverized to the size less than 80 meshes, then manufactured to a dry powered size less than 80 mesh, and sorted from foreign substances in the raw material sorter. The mixture comprises 65 weight percent of Momordica charantia powder, 7 weight percent of purple sweet potato powder, 5 weight percent of red ginseng extract, 10 weight percent of Gastrodia elata Blume powder, and 13 weight percent of Rhynchosia volubilis. The kneading is manufactured by adding purified water to the mixture at a rate of 40%(v/w) of moisture. The kneading is granulated at 0.3-0.5 cm in diameter and dried at 50-60°C for one day. The dried granules are formulated at 0.3-0.5 cm diameter of granules. Momordica charantia is prepared by washing immature Momordica charantia which is 25-30 cm in length and the moisture removed, and then cut in 4-6 mm thicknesses. [Reference numerals] (AA) Manufacture Momordica charantia powder; (BB) Harvest non-matured Momordica charantia(25-30cm); (CC) Wash and cut the Momordica charantia; (DD) Dry the Momordica charantia(45-55 deg. C, 2-3 days); (EE) Manufacture powdered Momordica charantia(80 mesh or less); (FF) Manufacture Momordica charantia granule; (GG) Raw material sorting process; (HH) Raw material mixing process(over or below 40% moisture); (II) Granulating process; (JJ) Granule drying process(50-60 deg. C, 1day); (KK) Granule adjusting process; (LL) Individual packaging process(Stick packaging); (MM) Commercialize granule A and granule B; (NN) Granule A: 65% of Momordica charantia, 7% of violet sweet potato powder, 5% of red ginseng liquid, 10% of Gastrodia, and 13% of Glycine max; (OO) Granule B: 100% of Momordica charantia